After receiving a B.S. in Chemistry with honors at California Institute of Technology, Dr. Wei entered the David Geffen School of Medicine at University of California, Los Angeles (UCLA), where she was awarded her M.D. and Ph.D. in Molecular Biology under the Medical Scientist Training Program Grant awarded by the National Institute of Health. Dr. Wei continued her residency training in Anatomic and Clinical Pathology at UCLA. As a trainee, she recognized and appreciated the expanding role of molecular pathology in daily clinical practice. In 2009, she entered a one-year fellowship in Molecular Genetic Pathology (MGP) under the mentorship of Dr. Wayne Grody at UCLA prior to joining Ambry Genetics in 2010. 

Mr. Caporale joined Ambry Genetics in November 2008 as chief financial officer. Since 1997 he has served as chief financial officer for various southern California publicly-traded companies operating principally in the insurance and pharmaceutical markets. Prior to 1997, Mr. Caporale served as senior vice president and chief financial officer of New York-based Minet, Inc., a wholly owned subsidiary of the St. Paul Companies. Mr. Caporale received his B.B.A. in Accounting from Pace University in New York. He is a New York State licensed CPA.

Mr. Arianpour currently serves as Vice President of Business Development at Ambry Genetics. Mr. Arianpour has more than 10 years of experience in life science sales, business development and strategic planning. Before joining Ambry Genetics, Mr. Arianpour was Manager of Business Development at Cogenics, a division of Clinical Data. Prior to that, he was with Eurogentec North America as Field Application Specialist and National Account Manager at DMI Medical, where he built sales and business opportunities throughout North America. Mr. Arianpour received a B.S. in Biological Sciences from the University of California, Irvine and a MBA in Strategic Management from Marshall Goldsmith School of Management at Alliant International University / University of California, San Diego.

Ms. Garcia has been with Ambry since 2009. She brings more than 14 years experience in accounts receivable, customer service and accessioning. She has 10 years of experience in the laboratory industry, having previously worked at Bio Med Laboratory & Westcliff Medical Laboratories.

Mr. Huerta is responsible for business development of the expanding clinical diagnostic division of Ambry Genetics. With more than 19 years of clinical diagnostic sales and global marketing experience, Mr. Huerta has achieved President’s Club status at Ciba Corning Diagnostics and Account Representative of the Year at both Therakos a J & J Co. and Oncotech Inc. He has also successfully built and managed sales teams at Bayer Diagnostics/Siemens Medical Solutions and most recently at Cepheid Diagnostics. Mr. Huerta holds a B.S. in Business Management from San Diego State University.

Mr. Robb is the public outreach director for Ambry Genetics where he helps raise awareness of genetic diseases in the community. A former professional surfer, he has won numerous national and world championships. Mr. Robb is considered one of the best surfers of his generation. He now combines his passion for surfing with his passion for helping others. In his current role, Mr. Robb deepens Ambry's relationship with schools, community groups and children's hospitals in ways that educate and inspire with special focus on brightening the spirits of young adults fighting genetic diseases.